Green tea and red wine extracts disrupt Alzheimer's
6th February 2013
Natural chemicals found in green tea and red wine may disrupt a key step of the Alzheimer's disease pathway, according to new faculty research.
In early-stage laboratory experiments, the researchers identified the process which allows harmful clumps of protein to latch on to brain cells, causing them to die. They were able to interrupt this pathway using the purified extracts of EGCG from green tea and resveratrol from red wine.
The findings, published in the Journal of Biological Chemistry, offer potential new targets for developing drugs to treat Alzheimer's disease, which affects some 800,000 people in the UK alone, and for which there is currently no cure.
"This is an important step in increasing our understanding of the cause and progression of Alzheimer's disease," says lead researcher Professor Nigel Hooper of the University's Faculty of Biological Sciences. "It's a misconception that Alzheimer's is a natural part of ageing; it's a disease that we believe can ultimately be cured through finding new opportunities for drug targets like this."
Alzheimer's disease is characterised by a distinct build-up of amyloid protein in the brain, which clumps together to form toxic, sticky balls of varying shapes. These amyloid balls latch on to the surface of nerve cells in the brain by attaching to proteins on the cell surface called prions, causing the nerve cells to malfunction and eventually die.
"We wanted to investigate whether the precise shape of the amyloid balls is essential for them to attach to the prion receptors, like the way a baseball fits snugly into its glove," says co-author Dr Jo Rushworth. "And if so, we wanted to see if we could prevent the amyloid balls binding to prion by altering their shape, as this would stop the cells from dying."
The team formed amyloid balls in a test tube and added them to human and animal brain cells. Professor Hooper said: "When we added the extracts from red wine and green tea, which recent research has shown to re-shape amyloid proteins, the amyloid balls no longer harmed the nerve cells. We saw that this was because their shape was distorted, so they could no longer bind to prion and disrupt cell function.
"We also showed, for the first time, that when amyloid balls stick to prion, it triggers the production of even more amyloid, in a deadly vicious cycle," he added.
Professor Hooper says that the team's next steps are to understand exactly how the amyloid-prion interaction kills off neurons. "I'm certain that this will increase our understanding of Alzheimer's disease even further, with the potential to reveal yet more drug targets," he said.
Dr Simon Ridley, Head of Research at Alzheimer's Research UK, the UK's leading dementia research charity, which part-funded the study, said: "Understanding the causes of Alzheimer's is vital if we are to find a way of stopping the disease in its tracks. While these early-stage results should not be a signal for people to stock up on green tea and red wine, they could provide an important new lead in the search for new and effective treatments. With half a million people affected by Alzheimer's in the UK, we urgently need treatments that can halt the disease - that means it's crucial to invest in research to take results like these from the lab bench to the clinic."
The research was funded by the Wellcome Trust, Alzheimer's Research UK and the Medical Research Council.
Last 3 months. View all
Vas Ponnambalam, Leverhulme Trust (1/09/2013), £245,031
Darren Tomlinson, Leverhulme Trust (1/09/2013), £5,645
Michelle Peckham, Gareth Howell, Roman Tuma, David Beech, Nigel Hooper, MRC (1/05/2013), £893,675
Sarah Calaghan, Derek Steele, BHF (1/05/2013), £208,005
Neil Messenger, EPSRC (1/04/2013), £618,675
Lars Jeuken, BBSRC (1/04/2013), £300,633
Ian Wood, Dunhill Medical Trust (1/04/2013), £113,705
Paul Millner, Wellcome Trust (1/04/2013), £40,000
Andrew Macdonald, Yorkshire Kidney Research Fund (1/04/2013), £39,886
Samit Chakrabarty, Royal Society (1/04/2013), £15,000
Sarah Zylinski, Royal Society (1/04/2013), £11,000
Urwin, Howard Atkinson, BBSRC (1/03/2013), £626,738
Charlotte Haigh, Wellcome Trust (1/03/2013), £50,000
Jim Deuchars, Leeds Teaching Hospitals Charitable Foundation (1/03/2013), £34,618
Carrie Ferguson, Wellcome Trust (1/03/2013), £27,700
Viewing last 3 months | View all items
Declines in the biodiversity of pollinating insects and wild plants have slowed in recent years, according to a new study. more
New research looks at how the management of farms and agricultural landscapes impacts on both pollinators of crops and natural enemies of crop pests. more
A key building block in the virus, which causes birth defects and stillbirths in sheep, goats and cattle, could be targeted by anti-viral drugs. more
A faculty-led study, published in the journal Ecology Letters, overturns the common assumption that evolution only occurs gradually over hundreds or thousands of years. more
The University of Leeds is leading a £5.7 million, government-backed initiative to transform the way replacement joints and other medical implants are made. more